Insider Transactions in Q3 2025 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2025
|
Kenneth W O'Keefe Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-5.92%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Patrick G Enright Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-6.4%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Jennifer E. Cook Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-14.28%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Heather Ann Mc Sharry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,959
-8.74%
|
$217,449
$111.25 P/Share
|
|
Aug 08
2025
|
Patrick Kennedy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,959
-22.62%
|
$217,449
$111.25 P/Share
|
|
Aug 08
2025
|
Laura Hamill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-20.66%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Mark Douglas Smith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-14.28%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Norbert G Riedel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-20.44%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Anne O Riordan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-9.86%
|
$200,355
$111.25 P/Share
|
|
Aug 08
2025
|
Rick E Winningham Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,805
-11.14%
|
$200,355
$111.25 P/Share
|
|
Aug 07
2025
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+10.32%
|
-
|
|
Aug 07
2025
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+11.07%
|
-
|
|
Aug 07
2025
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+21.72%
|
-
|
|
Aug 07
2025
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+13.53%
|
-
|
|
Aug 07
2025
|
Patrick Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+28.82%
|
-
|
|
Aug 07
2025
|
Laura Hamill Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+28.64%
|
-
|
|
Aug 07
2025
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+21.72%
|
-
|
|
Aug 07
2025
|
Norbert G Riedel Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+28.43%
|
-
|
|
Aug 07
2025
|
Anne O Riordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+16.08%
|
-
|
|
Aug 07
2025
|
Renee D Gala President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,808
+14.85%
|
-
|
|
Aug 07
2025
|
Seamus Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+0.3%
|
-
|
|
Aug 07
2025
|
Rick E Winningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,507
+17.8%
|
-
|
|
Aug 05
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-1.39%
|
$66,932
$116.1 P/Share
|
|
Aug 01
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$113,000
$113.21 P/Share
|
|
Jul 01
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.11%
|
$107,000
$107.63 P/Share
|